Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus.
二型糖尿病老年患者使用鈉-葡萄糖共轉運蛋白 2 抑制劑的益處與安全性。
Diabetes Metab J 2024-09-23
Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study.
鈉葡萄糖共同轉運蛋白2抑制劑與西他列汀在心衰竭和2型糖尿病中的比較:一項觀察性cohort研究。
Eur Heart J 2024-01-22
Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes.
老年東亞地區2型糖尿病患者使用SGLT2抑制劑的長期安全性和有效性。
J Diabetes Investig 2024-01-04
Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis.
老年或虛弱型2型糖尿病合併心臟衰竭患者中的鈉葡萄糖共同轉運蛋白2抑制劑(SGLT2):系統性回顧與荟萃分析。
Age Ageing 2024-02-01
The Efficacy and Safety of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors in Real-World Clinical Practice: Potential Cautionary Use in Elderly Patients with Type 2 Diabetes (T2D).
SGLT2 抑制劑在實際臨床實踐中的功效和安全性:對於老年 2 型糖尿病(T2D)患者的潛在警告使用。
Diabetes Ther 2024-05-21
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.
SGLT2 抑制劑在英國70歲以上2型糖尿病人群中的安全性和有效性:儀器變數方法。
Diabetologia 2024-06-05
Association of sodium-glucose cotransporter 2 inhibitors with risk of incident dementia and all-cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks.
鈉-葡萄糖共轉運蛋白 2 抑制劑與 2 型糖尿病老年患者新發癡呆風險及全因死亡率的關聯:基於 TriNetX 美國合作網絡的回顧性隊列研究。
Diabetes Obes Metab 2024-09-09
Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure in Patients With Type 2 Diabetes Mellitus: A Systematic Review.
鈉-葡萄糖共轉運蛋白-2 抑制劑對於2型糖尿病患者心臟衰竭的影響:系統性回顧。
Cureus 2024-10-04
The efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failure.
80歲以上心衰竭患者使用鈉-葡萄糖共轉運蛋白2抑制劑的療效與安全性。
ESC Heart Fail 2025-01-20
Safety and Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Older Adults with Variable Disease States: A Meta-analysis of Large Placebo-Controlled Trials.
鈉-葡萄糖共轉運蛋白 2 抑制劑在不同疾病狀態的老年人中的安全性和療效:大型安慰劑對照試驗的 meta-analysis。
Drugs Aging 2025-02-22
Update on the Efficacy and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis.
慢性疾病患者中鈉-葡萄糖共轉運蛋白 2 抑制劑的療效與安全性更新:系統性回顧與統合分析。
Medicina (Kaunas) 2025-02-26